Home > Insider Trading > Filing (0001209191-20-024476)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1446372	M Paul Silva	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Svp & Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-04-13	859	$90.29	15,791	No	4	M	Direct
Common Stock	Disposition	2020-04-13	50	$244.09	15,741	No	4	S	Direct
Common Stock	Disposition	2020-04-13	150	$245.62	15,591	No	4	S	Direct
Common Stock	Disposition	2020-04-13	150	$247.18	15,441	No	4	S	Direct
Common Stock	Disposition	2020-04-13	150	$248.96	15,291	No	4	S	Direct
Common Stock	Disposition	2020-04-13	193	$250.29	15,098	No	4	S	Direct
Common Stock	Disposition	2020-04-13	166	$252.26	14,932	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-04-13	859	$0.00	859	$90.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
860		2026-07-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	169	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $245.62 (range $245.31 to $246.00).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $247.18 (range $246.88 to $247.44).
Open market sales reported on this line occurred at a weighted average price of $248.96 (range $248.75 to $249.30).
Open market sales reported on this line occurred at a weighted average price of $250.29 (range $249.95 to $250.54).
Open market sales reported on this line occurred at a weighted average price of $252.26 (range $251.99 to $252.85).
The option vests in 16 quarterly installments from 07/12/2016.